Treatment With a Monocyte-Targeting Agent for Pancreatic Cancer
Published: | Updated:
Andrea Wang-Gillam, MD, PhD, discusses a trial looking at PF-04136309, an investigational chemokine receptor antagonist, in combination with FOLFIRINOX for the treatment of locally advanced pancreatic cancer.
